Showing 20 of 90 recruiting trials for “hereditary-attr-amyloidosis”
A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis
👨⚕️ Mirella Calcinai, MD, Medical Director, Clinical Development📍 3 sites📅 Started Feb 2026View details ↗
A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis (NDSLCA)
Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients
🏥 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.📍 23 sites📅 Started Dec 2025View details ↗
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
RecruitingNCT07218705 ↗
A Study Of MCG In Cardiac Amyloidosis
RecruitingNCT07448935 ↗
One Gene, Two Diseases: the Pathologic Role of IGLV1-44 in AL Amyloidosis and POEMS
RecruitingNCT07448779 ↗
Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment
Teclistamab-Daratumumab in AL Amyloidosis
RecruitingNCT07213297 ↗
Comprehensive Program for Hereditary Transthyretin Amyloidosis
Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis
Test-retest Study With [18F]FBB in Cardiac Amyloidosis
Multimodality Cardiac Imaging for Disease Progression in ATTR-CM
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
👨⚕️ Clinical Transparency (dept. 2834), Novo Nordisk A/S📍 285 sites📅 Started Oct 2025View details ↗
RecruitingNCT07301892 ↗
Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis
🏥 Guang'anmen Hospital of China Academy of Chinese Medical Sciences📍 1 site📅 Started Oct 2025View details ↗
RecruitingNCT07172243 ↗
BE.Amycon Biobank & Data Registry UZ Leuven
BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain Amyloidosis
RecruitingNCT07232459 ↗
[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Page 1 of 5Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →